Currently, the use of monoclonal antibodies is considered an extremely effective cancer treatment method. Monoclonal antibodies can trigger the immune system to attack and destroy cancer cells in the body. However, some monoclonal antibody drugs sometimes cause unwanted side effects for patients.

When a patient is diagnosed with cancer, a treatment plan is put in place. Doctors will sometimes recommend adjuvant treatment after primary treatment (surgery or radiation) has been completed. This is called adjuvant treatment to reduce the risk of the cancer coming back.

Lobrena contains the active ingredient Lorlatinib. This is a next-generation therapy in the latest targeted treatment of non-small cell lung cancer (NSCLC) on the ALK mutation.

Targeted therapy is a cancer treatment that uses drugs to target specific genes and proteins involved in cancer cell growth and survival. Targeted therapy can affect the tissue environment that helps the cancer grow and survive, or it can target cells involved in cancer growth, such as blood vessel cells. Doctors often use targeted therapy along with chemotherapy and other cancer treatments.